Godshalk Welsh Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,000
Closed -$207K 122
2024
Q3
$207K Buy
+4,000
New +$207K 0.13% 122
2024
Q2
Sell
-4,400
Closed -$239K 120
2024
Q1
$239K Sell
4,400
-1,200
-21% -$65.1K 0.16% 113
2023
Q4
$287K Hold
5,600
0.21% 105
2023
Q3
$325K Hold
5,600
0.25% 91
2023
Q2
$358K Sell
5,600
-150
-3% -$9.59K 0.25% 97
2023
Q1
$399K Sell
5,750
-100
-2% -$6.93K 0.28% 90
2022
Q4
$421K Sell
5,850
-80
-1% -$5.76K 0.31% 85
2022
Q3
$422K Buy
5,930
+380
+7% +$27K 0.31% 85
2022
Q2
$427K Sell
5,550
-300
-5% -$23.1K 0.31% 84
2022
Q1
$427K Hold
5,850
0.26% 90
2021
Q4
$365K Hold
5,850
0.21% 98
2021
Q3
$346K Buy
5,850
+250
+4% +$14.8K 0.22% 97
2021
Q2
$381K Sell
5,600
-200
-3% -$13.6K 0.24% 94
2021
Q1
$366K Sell
5,800
-200
-3% -$12.6K 0.26% 94
2020
Q4
$372K Hold
6,000
0.27% 86
2020
Q3
$362K Hold
6,000
0.31% 85
2020
Q2
$353K Hold
6,000
0.33% 83
2020
Q1
$334K Hold
6,000
0.36% 80
2019
Q4
$385K Buy
6,000
+1,300
+28% +$83.4K 0.32% 88
2019
Q3
$238K Hold
4,700
0.21% 100
2019
Q2
$213K Hold
4,700
0.2% 102
2019
Q1
$224K Buy
4,700
+500
+12% +$23.8K 0.22% 99
2018
Q4
$218K Buy
4,200
+400
+11% +$20.8K 0.24% 96
2018
Q3
$236K Sell
3,800
-150
-4% -$9.32K 0.23% 96
2018
Q2
$219K Hold
3,950
0.23% 102
2018
Q1
$250K Sell
3,950
-150
-4% -$9.49K 0.27% 98
2017
Q4
$251K Sell
4,100
-450
-10% -$27.5K 0.25% 106
2017
Q3
$290K Hold
4,550
0.29% 106
2017
Q2
$254K Sell
4,550
-350
-7% -$19.5K 0.25% 114
2017
Q1
$266K Buy
4,900
+650
+15% +$35.3K 0.26% 110
2016
Q4
$248K Hold
4,250
0.25% 115
2016
Q3
$229K Hold
4,250
0.24% 121
2016
Q2
$313K Hold
4,250
0.33% 102
2016
Q1
$271K Sell
4,250
-100
-2% -$6.38K 0.28% 112
2015
Q4
$299K Sell
4,350
-300
-6% -$20.6K 0.31% 109
2015
Q3
$275K Buy
4,650
+300
+7% +$17.7K 0.3% 115
2015
Q2
$289K Sell
4,350
-800
-16% -$53.1K 0.29% 116
2015
Q1
$332K Sell
5,150
-200
-4% -$12.9K 0.34% 103
2014
Q4
$316K Buy
+5,350
New +$316K 0.29% 113